Global Proton Pump Inhibitors (PPIs) Market 2024-2028

Global Proton Pump Inhibitors (PPIs) Market 2024-2028



The proton pump inhibitors (PPIs) market is forecasted to grow by USD 807.89 mn during 2023-2028, accelerating at a CAGR of 4.86% during the forecast period. The report on the proton pump inhibitors (PPIs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reformulation of drugs, growth in prescription rate, and strong prevalence of gastroesophageal reflux disease.

Technavio's proton pump inhibitors (PPIs) market is segmented as below:

By Product
  • OTC PPIs
  • Prescription PPIs
By Route Of Administration
  • Oral
  • Injectable
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing geriatric population as one of the prime reasons driving the proton pump inhibitors (PPIs) market growth during the next few years. Also, rising prevalence of obesity and personalized PPI therapy will lead to sizable demand in the market.

The report on the proton pump inhibitors (PPIs) market covers the following areas:
  • Proton pump inhibitors (PPIs) market sizing
  • Proton pump inhibitors (PPIs) market forecast
  • Proton pump inhibitors (PPIs) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proton pump inhibitors (PPIs) market vendors that include Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Perrigo Co. Plc, Pfizer Inc., RedHill Biopharma Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., The Procter and Gamble Co., and Zydus Lifesciences Ltd.. Also, the proton pump inhibitors (PPIs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global proton pump inhibitors (PPIs) market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 OTC PPIs - Market size and forecast 2023-2028
Exhibit 34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
6.4 Prescription PPIs - Market size and forecast 2023-2028
Exhibit 38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 46: Chart on Comparison by Route of Administration
Exhibit 47: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
Exhibit 48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Injectable - Market size and forecast 2023-2028
Exhibit 52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Exhibit 56: Market opportunity by Route of Administration ($ million)
Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 107: Amgen Inc. - Overview
Exhibit 108: Amgen Inc. - Product / Service
Exhibit 109: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 110: AstraZeneca Plc - Overview
Exhibit 111: AstraZeneca Plc - Product / Service
Exhibit 112: AstraZeneca Plc - Key news
Exhibit 113: AstraZeneca Plc - Key offerings
12.5 Aurobindo Pharma Ltd.
Exhibit 114: Aurobindo Pharma Ltd. - Overview
Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
12.6 Bausch Health Companies Inc.
Exhibit 117: Bausch Health Companies Inc. - Overview
Exhibit 118: Bausch Health Companies Inc. - Business segments
Exhibit 119: Bausch Health Companies Inc. - Key news
Exhibit 120: Bausch Health Companies Inc. - Key offerings
Exhibit 121: Bausch Health Companies Inc. - Segment focus
12.7 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key news
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.8 Dr Reddys Laboratories Ltd.
Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Eisai Co. Ltd.
Exhibit 131: Eisai Co. Ltd. - Overview
Exhibit 132: Eisai Co. Ltd. - Business segments
Exhibit 133: Eisai Co. Ltd. - Key offerings
Exhibit 134: Eisai Co. Ltd. - Segment focus
12.10 Eli Lilly and Co.
Exhibit 135: Eli Lilly and Co. - Overview
Exhibit 136: Eli Lilly and Co. - Product / Service
Exhibit 137: Eli Lilly and Co. - Key news
Exhibit 138: Eli Lilly and Co. - Key offerings
12.11 Glenmark Pharmaceuticals Ltd.
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 Pfizer Inc.
Exhibit 142: Pfizer Inc. - Overview
Exhibit 143: Pfizer Inc. - Product / Service
Exhibit 144: Pfizer Inc. - Key news
Exhibit 145: Pfizer Inc. - Key offerings
12.13 Sun Pharmaceutical Industries Ltd.
Exhibit 146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 147: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 148: Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Takeda Pharmaceutical Co. Ltd.
Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 152: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 The Procter and Gamble Co.
Exhibit 158: The Procter and Gamble Co. - Overview
Exhibit 159: The Procter and Gamble Co. - Business segments
Exhibit 160: The Procter and Gamble Co. - Key news
Exhibit 161: The Procter and Gamble Co. - Key offerings
Exhibit 162: The Procter and Gamble Co. - Segment focus
12.17 Zydus Lifesciences Ltd.
Exhibit 163: Zydus Lifesciences Ltd. - Overview
Exhibit 164: Zydus Lifesciences Ltd. - Business segments
Exhibit 165: Zydus Lifesciences Ltd. - Key offerings
Exhibit 166: Zydus Lifesciences Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits45: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Route of Administration ($ million)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Amgen Inc. - Overview
Exhibits108: Amgen Inc. - Product / Service
Exhibits109: Amgen Inc. - Key offerings
Exhibits110: AstraZeneca Plc - Overview
Exhibits111: AstraZeneca Plc - Product / Service
Exhibits112: AstraZeneca Plc - Key news
Exhibits113: AstraZeneca Plc - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bausch Health Companies Inc. - Overview
Exhibits118: Bausch Health Companies Inc. - Business segments
Exhibits119: Bausch Health Companies Inc. - Key news
Exhibits120: Bausch Health Companies Inc. - Key offerings
Exhibits121: Bausch Health Companies Inc. - Segment focus
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Dr Reddys Laboratories Ltd. - Overview
Exhibits128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits131: Eisai Co. Ltd. - Overview
Exhibits132: Eisai Co. Ltd. - Business segments
Exhibits133: Eisai Co. Ltd. - Key offerings
Exhibits134: Eisai Co. Ltd. - Segment focus
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key news
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: Pfizer Inc. - Overview
Exhibits143: Pfizer Inc. - Product / Service
Exhibits144: Pfizer Inc. - Key news
Exhibits145: Pfizer Inc. - Key offerings
Exhibits146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits147: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits148: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits150: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits152: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits157: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits158: The Procter and Gamble Co. - Overview
Exhibits159: The Procter and Gamble Co. - Business segments
Exhibits160: The Procter and Gamble Co. - Key news
Exhibits161: The Procter and Gamble Co. - Key offerings
Exhibits162: The Procter and Gamble Co. - Segment focus
Exhibits163: Zydus Lifesciences Ltd. - Overview
Exhibits164: Zydus Lifesciences Ltd. - Business segments
Exhibits165: Zydus Lifesciences Ltd. - Key offerings
Exhibits166: Zydus Lifesciences Ltd. - Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings